The effect of tiotropium in COPD complicated with asthma

T. Iwanaga, E. Naito, H. Ichihashi, S. Kitaguchi, Y. Ikeda, A. Sano, R. Sato, F. Tsuji, T. Miyara, H. Sano, M. Muraki, H. Kubo, Y. Tohda (Osakasayama, Osaka, Japan)

Source: Annual Congress 2007 - New insights into the treatment of COPD
Session: New insights into the treatment of COPD
Session type: Thematic Poster Session
Number: 3588
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Iwanaga, E. Naito, H. Ichihashi, S. Kitaguchi, Y. Ikeda, A. Sano, R. Sato, F. Tsuji, T. Miyara, H. Sano, M. Muraki, H. Kubo, Y. Tohda (Osakasayama, Osaka, Japan). The effect of tiotropium in COPD complicated with asthma. Eur Respir J 2007; 30: Suppl. 51, 3588

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The effect of tiotropium in the treatment of patients with COPD
Source: Annual Congress 2010 - COPD: management
Year: 2010


The effect of inhaler switching on asthma and COPD patients
Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Year: 2018



The effect of bronchiectasis on asthma exacerbations
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012


Additive benefits of tiotropium in asthmatics and in patients with asthma complicated chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 546s
Year: 2007

The effect of formoterol in elderly COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 122s
Year: 2005

The effect on mortality of adding inhaled corticosteroids to long-acting bronchodilators for COPD: A focus on the frequent exacerbator phenotype
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015

Formoterol given either alone or together with tiotropium, reduces the rate of exacerbations in stable COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 430s
Year: 2006

Bronchodilator treatment for asthma and COPD
Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD
Year: 2010

Bronchodilator efficacy of tiotropium in patients with mild COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 616s
Year: 2006

QVA149 improves lung function and reduces exacerbations compared to tiotropium in patients with severe-to-very severe COPD: The SPARK study
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013

FORWARD: A study of extrafine beclomethasone/formoterol compared with formoterol alone in patients with severe COPD and a history of exacerbations
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013

The direct costs of exacerbations in COPD and the effect of cilomilast treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 245s
Year: 2002

Comparison of fluticasone, roflumilast and tiotropium in a model of influenza-induced acute COPD exacerbation
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013

Baseline characteristics of COPD patients with frequent COPD exacerbations in tiotropium trials
Source: Eur Respir J 2006; 28: Suppl. 50, 175s
Year: 2006

Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Dual bronchodilation with once-daily QVA149 improves lung function and reduces exacerbations in patients with COPD: The IGNITE trials
Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs
Year: 2013

Budesonide/formoterol added to tiotropium improves exacerbations and exacerbation-related antibiotic use in patients with COPD
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009

Dual bronchodilation with once-daily QVA149 reduces exacerbations, improves lung function and health status versus glycopyrronium and tiotropium in severe-to-very severe COPD patients: The SPARK study
Source: Annual Congress 2013 –New bronchodilators for COPD management
Year: 2013

Clinical effectiveness of nebulized budesonide in the treatment of acute asthma and exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 146s
Year: 2001

Ceruloplasmine efficacy in patients with asthma exacerbations
Source: Annual Congress 2011 - Novel mechanisms in lung injury
Year: 2011